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Vancomycin-resistant enterococci (VRE) have emerged in many parts of the world, but have only
been reported sporadically in Hong Kong. We report an outbreak of vancomycin-resistant
Enterococcus faecium (VREfm) in a neurosurgical unit at a tertiary teaching hospital between 3
March and 3 April 2009 in Hong Kong. During the outbreak investigation, clinical samples from
193 (91.5%) of 211 patients who had stayed in the neurosurgical unit and 506 environmental
samples were screened for VREfm. Besides the index case, another 3 (1.6%) out of 192 patients
were found to be positive for VREfm. Two (0.4%) out of 506 environmental samples were
positive for VREfm. All four clinical and two environmental isolates were found to be clonally
related by pulse-field gel electrophoresis. The risk factors for nosocomial acquisition of VREfm
included advanced age (P¼0.047), presence of nasogastric tubing (P¼0.002) and tracheo-
stomy (Po0.001), and the use of b-lactam antibiotics (Po0.001) and vancomycin (P¼0.001).
Contrary to other VRE outbreaks in which the spread was rapid, the neurosurgical patients’
immobilization because of coma and mechanical ventilation dependency, and the vigilant
practice of hand hygiene by health-care workers successfully limited the number of secondary
cases despite the delayed recognition of the index case. All patients with VREfm were labeled in
the hospital network information system so that stringent infection control measures with
contact precautions would be carried out once these patients were readmitted to prevent its
spread in our locality.
Introduction
Since the initial reports of vancomycin-resistant enterococci
(VRE) in France and the United Kingdom in 1986,
1,2 VRE
have spread throughout the world and have become a major
cause of nosocomial infections. During the 1990s, a
significant increase of VRE was observed in the United States
from 0.3% in 1989 to over 28% of all isolates in 2004.
3,4
Recently, VRE have emerged in Asian countries such as
Singapore, Japan, Korea, and China
5–9 but have seldom been
reported in Hong Kong. In an active surveillance study in a
regional hospital between 2001 and 2002, only 1 out of 1792
patients being screened was found to harbor VRE in the
stool.
10 Reported risk factors for gastrointestinal colonization
of VRE include hospitalization, residence in long-term care
facilities, use of antibiotics, renal replacement therapy, and
admission to high-risk clinical areas.
11–16 Here, we report an
outbreak of vancomycin-resistant E. faecium (VREfm) in our
neurosurgical unit. Extensive investigation of the source,
contact tracing of the potential secondary cases, and
environmental surveillance were performed to control the
spread of VREfm in a non-endemic area.
Methods
Epidemiological investigation
The neurosurgical unit at Queen Mary Hospital (hospital A),
a university-affiliated teaching hospital in Hong Kong, serves
as a tertiary referral center with the provision of acute
neurosurgical and intensive care support in wards A7 and
C7, respectively. Between 3 March and 3 April 2009, an
outbreak of VREfm involving four cases occurred in wards A7
and C7 of hospital A. Contact tracing and screening culture
of all patients who were discharged or transferred to
convalescence hospitals (hospitals B, C, D, and E) during
that period were performed. Environmental screening was
done to assess the degree of contamination by sampling
bedside rails, tables, lockers, bed linens, medical charts, drip
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facilities, and nursing stations (computer keyboards and
controls, telephones, scanning machines, medical trolleys,
and drug refrigerators) with premoistened swabs. Screening
of stools for VREfm was offered to the relatives of patients
with VREfm colonization. Cases were defined as those with
positive culture of VREfm in either stool or rectal swabs.
Their demographic data, clinical features, use of antibiotics,
and co-morbidity were obtained using a standardized record
form as previously described.
17,18 A case–control study was
performed to assess the risk factors for acquisition of VREfm,
with the control patients being selected as those who had
been staying within the same cubicle as the cases in hospital
A and B, but with a negative stool or rectal swab culture for
VRE. The study was approved by the institutional review
board.
Laboratory investigation
Either stool or rectal swab with visible fecal component
was collected, with stool being the preferred specimen.
Cultures were performed within 24h of specimen collection
by inoculation onto chromogenic agar (chromID VRE,
CHROMagar GRE). The Kirby–Bauer disk diffusion method
and E-test (AB Biodisk, Solna, Sweden) were used to
determine the susceptibility of the enterococci according to
the Clinical and Laboratory Standards Institute or the
manufacturer’s instructions. Isolates with potential vanco-
mycin resistance were confirmed by polymerase chain
reaction as previously described.
19 Primers for identification
of E. faecium (F1 and F2 for ddIE. faecium) and the
vancomycin resistance genotype (VanA, VanB, VanC1, and
Van C23) were used.
20 Pulsed-field gel electrophoresis (PFGE)
of the clinical and environmental isolates was performed
according to a standard protocol as previously described.
21
Statistical analysis
Chi-square test and Fisher’s exact test were used in the
analysis where appropriate. All reported P-values are two-
sided. Po0.05 was considered statistically significant in
all analyses. Computations were performed with the use
of SPSS version 15.0 for Windows.
Results
Epidemiological investigation
On 28 March 2009, VREfm was isolated from the catheter-
ized urine in a 77-year-old man (patient 1) hospitalized
in the neurosurgical unit (ward A7 and C7) of hospital A
since 5 March 2009. The infection control team was
informed and conducted an outbreak investigation. The first
patient was immediately transferred into an isolation room
with contact precautions and 28 other patients in the same
unit were screened. VREfm were detected in the stool
samples of two other patients including a 62-year-old
woman (patient 2) and a 75-year-old man (patient 3). The
starting date of the outbreak period was thus defined as 3
March 2009, the day on which patient 3 was admitted.
Further contact tracing was performed which included 58
patients who had been transferred to the four convalescent
hospitals since 3 March 2009 and remained hospitalized at
the time of investigation. The VREfm was isolated from
the stool of another 89-year-old man (patient 4) who was
transferred to hospital B on 16 March 2009. Seventy-one out
of 89 patients discharged from hospital A and another 35
patients staying with patient 4 in hospital B were traced and
screened for VREfm. A total of 192 patients were screened
with three (1.6%) of them being positive for VREfm. All
patients confirmed to be VREfm positive were cared for in
isolation rooms with contact precautions, and hand hygiene
was enforced with emphasis on directly observed hand
hygiene practice. Seven specimens from seven household
members (one specimen each) of patients 1, 2, and 3 were
found negative for VRE in voluntary screening. A total of 440
and 66 environmental samples were collected in hospital A
and hospital B, respectively, and two of them taken in
hospital B (bedside table and milk container) were positive
for VREfm in both direct inoculation and after broth
enrichment culture.
Although patient 1 was the first identified case with both
urine and gastrointestinal colonization of VREfm, epidemiolo-
gical investigation showed that patient 4 could be the possible
index case of this outbreak (Figure 1). He was directly
transferred from a hospital in Mainland China and admitted
to the neurosurgical intensive care unit in ward C7, bed
number 3 (C7/3), for chronic subdural hematoma on
3 March 2009. He was given cefazolin as perioperative
prophylaxis, and treated with intravenous ticarcillin–clavula-
nate and gentamicin for nosocomial pneumonia. When the
index case was transferred to A7/6 and A7/12 on 7 March 2009
and 10 March 2009, respectively, the VREfm might have
spread to patient 3 who was staying in A7/10 and receiving
antimicrobial therapy for sepsis of unknown origin. When
patient 3 deteriorated with clinical evidence of nosocomial
pneumonia, he was transferred to C7/1 and was treated with
intravenous piperacillin–tazobactam and vancomycin from 13
March 2009 onwards. The VREfm might have then further
spread to patients 1 and 2 who were staying at C7/2 and C7/4,
respectively. However, alternative sources and sequences of
transmission were also possible as patients 1 and 4 had stayed
in the same ward (C7/5 and C7/3) during the first few days of
admission. Patient 4 was transferred to a convalescent hospital
B on 16 March 2009 and detected to have VRE colonization in
the stool on 2 April 2009. No secondary spread of VREfm was
detected in the four convalescent hospitals receiving cases from
the neurosurgical unit.
None of the four cases had symptoms suggestive of
invasive VREfm infection. Except for patient 4 who died
of his underlying disease, all patients recovered from the
acute neurosurgical condition. These patients were labeled
as being colonized by VREfm in the hospital network
information system in order for the infection control team
to implement appropriate measures if these patients are
admitted to the hospital in future.
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factors for nosocomial acquisition of VREfm (Table 1). There
were four cases and 32 controls who were the patients
staying in the same wards with the cases during their
hospitali-
zation in hospitals A and B. The statistically significant risk
factors for acquisition included advanced age (P¼0.047),
presence of indwelling nasogastric tube (P¼0.002) and
endotracheal tube (Po0.001), and the use of antibiotics
(P¼0.001) during the contact period, particularly with
b-lactams (Po0.001) and vancomycin (P¼0.001). The differ-
ence in 30-day mortality after discharge was not statistically
significant.
Laboratory investigation
The four isolates of E. faecium from patients’ stool or rectal
swabs, and two isolates from the environment were char-
acterized using a Vitek identification card. Their biochemical
profiles and drug susceptibility patterns by disk diffusion test
are listed in Table 2. All possessed Van A gene with minimum
Table 1 Potential risk factors for acquisition of vancomycin-resistant
Enterococcus faecium in the neurosurgical unit
Case (n¼4) Control (n¼32)
a P-value
Age (mean) 75.8 55.8 0.047
Sex (male/female) 3:1 17:15 0.613
Underlying disease
Cardiorespiratory disease 3 15 0.603
Malignancy 0 16 0.113
Indwelling device
Nasogastric tubing 3 1 0.002
Tracheostomy 4 1 o0.001
Urinary catheter 3 13 0.303
Current use of antimicrobials
b
All antimicrobials 4 2 0.001
b-lactam 4 2 o0.001
Vancomycin 3 0 0.001
Others 1 1 0.213
a26 patients from hospital A and 6 patients from hospital B.
bAt the time when
the stool or rectal swab was collected.
Figure 1 In-patient relationships and movements of the four patients with vancomycin-resistant Enterococcus faecium (VRE) in the neurosurgical unit of hospital A
(unless specified) and details of their antimicrobial utilization. Solid blocks in yellow (C7) and green (A7)¼days in which the patients stayed in the respective wards
and beds in hospital A. Solid blocks in purple¼days in which the patient stayed in hospital B. Dotted block in blue¼days in which patients 1, 2, and 3 were staying
in the same ward. Dotted block in red¼days in which patients 3 and 4 were staying in the same ward.
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PFGE analysis showed that all four clinical and two
environmental isolates were clonally related (Figure 2).
Discussion
VRE are uncommon in Hong Kong. Over the past 10 years,
sporadically imported cases of VRE colonization or infection
have been detected and outbreaks of limited scale have been
reported in renal and orthopedic units (unpublished data).
As enterococci constitute part of the normal gut flora,
eradication after colonization in the gastrointestinal tract
is very difficult and shedding of VRE can be for as long as
2 years.
22 Therefore, whenever a case of colonization or
infection is identified, stringent infection control measures
are adopted to prevent their spread in our locality. However,
it has become more difficult to maintain Hong Kong free
of VRE as VRE have emerged in various parts of Asia.
The increasing number of cases in Mainland China is
of particular concern as there are occasional transferals
of patients between the two areas.
8,9,23 Our index case
(patient 4), who had been hospitalized in Mainland China
before returning to Hong Kong, might have acquired the
infection there.
Prolonged utilization of broad-spectrum antibiotics may
also predispose to VRE acquisition during hospitalization.
The VRE colonization status of our index case was unknown
because screening of stool or rectal swab for VRE was not
routinely performed. The routine screening of VRE in non-
endemic areas has not been found to be cost-effective
because the microbial load of VRE may be well below the
detection limit of standard culturing methods unless the
patient is on antibiotics.
24 The hypothesis that suppression
of the gut flora by broad-spectrum antimicrobials would
render patients susceptible to VRE colonization, is in
accordance with our case–control analysis, which illustrates
that the secondary colonized cases in the present outbreak
may have acquired VRE while on antibiotics.
24
The outbreak was identified when a catheterized urine
specimen from patient 1 was positive for VRE. As patient 1
became bedridden after a neurosurgical operation and diaper
care was required, contamination of the urinary catheter by
fecal material may have occurred. To prevent the nosocomial
transmission of VRE through the care of urinary catheter
by health-care workers, catheterized urine was obtained
from 25 hospitalized patients to ensure that this mode
of transmission did not occur (data not shown). Three
secondary cases were identified after contact tracing of
almost 200 contacts, making the clinical attack rate less
than 2%. This is much lower than the previously reported
figure of more than 5%.
25 There are a number of reasons
to explain this apparent discrepancy. First, the immobiliza-
tion of comatose and ventilator-dependent neurosurgical
patients limited patient-driven environmental contamina-
tion. This was demonstrated by the limited number of
positive cultures for VRE among our extensive environ-
mental surveillance including more than 500 swabs. Only
two environmental samples taken from a bedside table and
a milk container were positive for the same strain of VREfm.
The absence of diarrhea in all of our cases limited environ-
mental contamination because the microbial load in the
stool remained low during colonization.
26 Enforcement of
Table 2 Laboratory characteristics of four isolates of vancomycin-resistant Enterococcus faecium
Patient 1 Patient 2 Patient 3 Patient 4 Environment 1 Environment 2
Strain number 8045 8890 8956 1318 6318 6319
Date of collection 28 March 2009 30 March 2009 30 March 2009 3 April 2009 6 April 2009 6 April 2009
Specimen Rectal swab Rectal swab Rectal swab Stool Bedside table Milk container
Vitek identification E. faecium (99%) E. faecium (99%) E. faecium (99%) E. faecium (99%) E. faecium (99%) E. faecium (99%)
Vancomycin MIC (E-test) 4256mg/ml 4256mg/ml 4256mg/ml 4256mg/ml 4256mg/ml 4256mg/ml
Van A gene Present Present Present Present Present Present
Resistance pattern
a Amp, Gen,
Lev, Nit, Rif
Amp, Gen,
Lev, Nit, Rif
Amp, Gen,
Lev, Nit, Rif
Amp, Gen,
Lev, Nit, Rif
Amp, Gen,
Lev, Nit, Rif
Amp, Gen,
Lev, Nit, Rif
aAll the isolates were resistant to Amp, ampicillin; Gen, gentamicin (high content); Lev, levofloxacin; Nit, nitrofurantoin; Rif, rifampin; but susceptible to
chlormaphenicol, fosfomycin, linezolid, minocycline, tetracycline, tigecycline, and streptomycin (high content).
Figure 2 PFGE patterns of SmaI-digested DNAs of vancomycin-resistant
Enterococcus faecium. Lane 1 and 10, molecular sizes are shown in kilobases;
lane 2, patient 1 (8045), lane 3, patient 2 (8890); lane 4, patient 3 (8956);
lane 5, patient 4 (1318); lane 6, environmental strain 1 (6318); lane 7,
environmental strain 2 (6319); lane 8, unrelated patient strain 1 from
another hospital (301036); lane 9, unrelated patient strain 2 from another
hospital (304631)
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role in limiting the scale of both nosocomial transmission to
patients and environmental contamination.
18,27,28
The major limitation in this study is the small number of
cases, which does not allow a more meaningful case–control
analysis. On the other hand, the present data reinforces the
importance of compliance to infection control measures and
clinical alertness, especially when inter-hospital transferal of
patients is involved, in preventing major outbreaks of VRE
infection.
29 Therefore, we advocate that stringent infection
control measures of contact isolation and hand hygiene
must be implemented even when colonization of VRE is
apparently cleared. As shown in a previous study, VRE may
become detectable when colonized patients are treated
with antibiotics,
30 which is similar to our past experiences
involving multidrug-resistant Staphylococcus aureus (MRSA)
and community-acquired MRSA where antibiotic treatment
would unmask colonization status.
31,32
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